Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

IIndaptus Therapeutics, Inc.

EconomyAI buildoutMarket MapFundsWatchlist
Log in
I

Indaptus Therapeutics, Inc.

  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • News
  • Insider Transactions
Loading insider transactions

Insider transactions

Insider sentiment

Insider transactions

Insider sentiment

SellBuy
DateNameTitleSharesValueTransactionSource
Mar 23, 2026Lazar David E.Director700,000Series AAA Convertible Non-Redeemable Preferred Stock$1.2MSell
Mar 23, 2026Lazar David E.Director196,800Series AA Convertible Non-Redeemable Preferred Stock$334.6KSell
Feb 26, 2026Jabbour Jerome DDirector25,000Option to Buy Common Stock$50.5KGrant / award
Feb 11, 2026Meckler Jeffrey ACo-Chief Executive Officer12,136Warrants (right to buy)$21.8KGrant / award
Feb 11, 2026Meckler Jeffrey ACo-Chief Executive Officer12,136Warrants (right to buy)$21.8KOther
Feb 11, 2026Meckler Jeffrey ACo-Chief Executive Officer1,519Warrants (right to buy)$2.7KGrant / award
Feb 11, 2026Meckler Jeffrey ACo-Chief Executive Officer1,519Warrants (right to buy)$2.7KOther
Feb 11, 2026Meckler Jeffrey ACo-Chief Executive Officer3,033Warrants (right to buy)$5.5KGrant / award
Feb 11, 2026Meckler Jeffrey ACo-Chief Executive Officer3,033Warrants (right to buy)$5.5KOther
Jan 20, 2026Ben-Tzvi AvrahamDirector25,000Common Stock$85.8KGrant / award
…
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Burn Rate
  • Similar companies
  • Insider Transactions
$3.99Close · Sep 22, 2026